(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CADENT MEDICAL COMMUNICATIONS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CADENT MEDICAL COMMUNICATIONS

ST13

US500000087784825

Class

35, 41

Filing

87784825

Registration

5731076

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

11/19/2025

Trademark type

Combined

Nice classes

35, 41

Filing date

02/05/2018

Registration date

04/23/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/18/2025

Last transaction

11/19/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

01/08/2018

First use in commerce

01/08/2018

Drawing code

3

Owner type

03

Owner location

MORRISVILLE, NC

Examiner

ESTRADA,LINDA M

Current location

Historical data usage

Mark description

The mark consists of a double helix above the word "CADENT" with "MEDICAL COMMUNICATIONS" under "CADENT".

Holders and representatives

Holders

SYNEOS HEALTH COMMUNICATIONS, INC.
inVentiv Health, Inc.

Representatives

Michael A. Geller DLA Piper LLP (US)

Technical classification

Nice Classes

Class 35Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business management of speaker bureaus

Class 41

Educational servicesarranging and conducting of colloquiumsseminarssymposiums and conferencespractical training all in the field of medicinepharmaceuticals and biotechnology; speaker bureau managementproviding educational speakers in the field of medicinepharmaceuticals and biotechnology

Publications

History of USPTO decisions and trademark events.

27 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/18/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/18/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/18/2025

E815

TEAS SECTION 8 & 15 RECEIVED

08/01/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/11/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/23/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/04/2023

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

03/15/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

04/23/2019

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/10/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/02/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/02/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/05/2019

PUBO

PUBLISHED FOR OPPOSITION

02/05/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/16/2019

ALIE

ASSIGNED TO LIE

12/31/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/11/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/26/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/26/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/26/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/24/2018

GNRT

NON-FINAL ACTION E-MAILED

05/24/2018

CNRT

NON-FINAL ACTION WRITTEN

05/24/2018

DOCK

ASSIGNED TO EXAMINER

05/17/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

02/14/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/13/2018

NWAP

NEW APPLICATION ENTERED

02/08/2018

Continuous trademark protection

Get notified about every new filing that threatens CADENT MEDICAL COMMUNICATIONS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.